Sarcoidosis and tuberculosis: The same disease with different manifestations or similar manifestations of different disorders

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 5, 2012, Pages 506-516

  Gupta, Dheeraj ^a   Agarwal, Ritesh ^a   Aggarwal, Ashutosh N ^a   Jindal, Surinder K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

immune responses; interferon release assays; nucleic acid amplification techniques; PCR; Quantiferon sarcoidosis; tuberculosis

Indexed keywords

BACTERIAL DNA; EPITOPE; GAMMA INTERFERON; GLUCOCORTICOID; HEAT SHOCK PROTEIN; MYCOBACTERIUM ANTIGEN; SUPEROXIDE DISMUTASE; TUBERCULOSTATIC AGENT;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL PRACTICE; CYTOKINE RELEASE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PREVALENCE; REVIEW; SARCOIDOSIS; SEROLOGY; T LYMPHOCYTE; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

ANTIGENS, BACTERIAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG; MYCOBACTERIUM; PREVALENCE; SARCOIDOSIS; TUBERCULOSIS;

EID: 84864865382     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283560809     Document Type: Review

References (124)

1. Newman LS. Aetiologies of sarcoidosis. Eur Resp Mon 2005; 32:23-48.
2. Brownell I, Ramirez-Valle F, Sanchez M, Prystowsky S. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol 2011; 45:899-905.
3. Gupta D, Sharma OP. Sarcoidosis. In: Jindal SK, Gupta D, Shankar PS, et al., editors. Text book of pulmonary and critical care medicine. Delhi: Jaypee; 2010. pp. 1188-1216.
4. Perez RL, Rivera-Marrero CA, Roman J. Pulmonary granulomatous inflammation: From sarcoidosis to tuberculosis. Semin Respir Infect 2003; 18:23-32. (Pubitemid 36373413)
5. Thomeer M, Demedts M, Wuyts W. Epidemiology of sarcoidosis. Eur Respir Mon 2005; 32:13-22.
6. du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003; 253:4-17. (Pubitemid 36120993)
7. Vidal S, de la Horra C, Martin J, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect 2006; 12:231-235. (Pubitemid 43379323)
8. Drake WP, Newman LS. Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 2006; 12:359-363. (Pubitemid 44315782)
9. Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:33-42. (Pubitemid 40444732)
10. Oswald-Richter KA, Drake WP. The etiologic role of infectious antigens in sarcoidosis pathogenesis. Semin Respir Crit Care Med 2010; 31:375-379.
11. Bunn DT, Johnston RN. A ten-year study of sarcoidosis. Br J Dis Chest 1972; 66:45-52.
12. Parsons V. Awareness of family and contact history of tuberculosis in generalized sarcoidosis. Br Med J 1960; 2:1756-1759.
13. Brett GZ. Epidemiological trends in tuberculosis and sarcoidosis in a district of London between 1958 and 1963. Tubercle 1965; 46:413-416.
14. Hosoda Y, Sasagawa S, Yamaguchi T. Sarcoidosis and tuberculosis: epidemiological similarities and dissimilarities. A review of a series of studies in a Japanese work population (1941-1996) and the general population (1959-1984). Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:85-93. (Pubitemid 38954748)
15. Selroos O. The frequency, clinical picture and prognosis of pulmonary sarcoidosis in Finland. Acta Med Scand Suppl 1969; 503:3-73.
16. Mise K, Jurcev-Savicevic A, Goic-Barisic I, et al. Sarcoidosis and tuberculosis in South Croatia: are there epidemiological similarities or not? Public health 2011; 125:734-737.
17. Global tuberculosis control: WHO report 2011. http://www.who.int/entity/ tb/publications/global-report/2011/gtbr11-full.pdf. [Accessed 29 March 2012].
18. Taub RN, Sachar D, Janowitz H, Siltzbach LE. Induction of granulomas in mice by inoculation of tissue homogenates from patients with inflammatory bowel disease and sarcoidosis. Ann N Y Acad Sci 1976; 278:560-564.
19. Mitchell DN, Rees RJ. A transmissible agent from sarcoid tissue. Lancet 1969; 2:81-84.
20. Parkes SA, Baker SB, Bourdillon RE, et al. Epidemiology of sarcoidosis in the Isle of Man-1: a case controlled study. Thorax 1987; 42:420-426. (Pubitemid 17080661)
21. Burke BJ, Parker SH, Hopper KD, Pienkos EJ. The ultrasonographic appearance of coexistent epididymal and testicular sarcoidosis. J Clin Ultrasound 1990; 18:522-526. (Pubitemid 20194485)
22. Heyll A, Meckenstock G, Aul C, et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14:161-164. (Pubitemid 24228756)
23. Vanek J, Schwarz J. Demonstration of acid-fast rods in sarcoidosis. Am Rev Respir Dis 1970; 101:395-400.
24. Moscovic EA. Sarcoidosis and mycobacterial L-forms. A critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes. Pathol Annu 1978; 13 (Pt 2):69-164.
25. Cantwell AR Jr. Histologic observations of variably acid-fast pleomorphic bacteria in systemic sarcoidosis: a report of 3 cases. Growth 1982; 46:113-125. (Pubitemid 13243503)
26. Scadding JG. Mycobacterium tuberculosis in the aetiology of sarcoidosis. Br Med J 1960; 2:1617-1623.
27. Riley EA. Boeck's sarcoid; a review based upon a clinical study of fifty-two cases. Am Rev Tuberc 1950; 62:231-285.
28. Belcher RW, Reid JD. Sarcoid granulomas in CBA/J mice. Histologic response after inoculation with sarcoid and nonsarcoid tissue homogenates. Arch Pathol 1975; 99:283-285.
29. Brown ST, Brett I, Almenoff PL, et al. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 2003; 123:413-417. (Pubitemid 36269423)
30. Emerson PA, Young FH. Sarcoidosis following tuberculosis. Tubercle 1956; 37:116-119.
31. Lees AW. Transition from open pulmonary tuberculosis to sarcoidosis. Am Rev Tuberc 1958; 78:769-772.
32. Giotaki HA, Stefanou DG. Biopsy-documented tuberculous pleural effusion in a patient with biopsy-proven coexisting sarcoidosis. Respiration 1988; 54:193-196.
33. Mitchell DN. Mycobacteria and sarcoidosis. Lancet 1996; 348:768-769. (Pubitemid 26308476)
34. Mitchell DN, Rees RJ, Goswami KK. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet 1976; 2:761-765.
35. Smith-Rohrberg D, Sharma SK. Tuberculin skin test among pulmonary sarcoidosis patients with and without tuberculosis: its utility for the screening of the two conditions in tuberculosis-endemic regions. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23:130-134. (Pubitemid 47471832)
36. el-Zaatari FA, Graham DY, Samuelsson K, Engstrand L. Detection of Mycobacterium avium complex in cerebrospinal fluid of a sarcoid patient by specific polymerase chain reaction assays. Scand J Infect Dis 1997; 29:202-204.
37. Greally JF, Manning D, McNicholl B. Sarcoidosis following B.C.G. vaccination in a lymphopaenic boy. Sarcoidosis 1989; 6:156-157.
38. Osborne GE, Mallon E, Mayou SC. Juvenile sarcoidosis after BCG vaccination. J Am Acad Dermatol 2003; 48:S99-S102. (Pubitemid 36583271)
39. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007; 30:508-516. (Pubitemid 351182075)
40. Mootha VK, Agarwal R, Aggarwal AN et al. The sarcoid-tuberculosis link: evidence from a high TB prevalence country. J Infect 2010; 60:501-503.
41. Bocart D, Lecossier D, De Lassence A, et al. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992; 145:1142-1148.
42. Gerdes J, Richter E, Rusch-Gerdes S, et al. Mycobacterial nucleic acids in sarcoid lesions. Lancet 1992; 339:1536-1537.
43. Mitchell IC, Turk JL, Mitchell DN. Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet 1992; 339:1015-1017.
44. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339:1012-1015.
45. Thakker B, Black M, Foulis AK. Mycobacterial nucleic acids in sarcoid lesions. Lancet 1992; 339:1537.
46. Fidler HM, Rook GA, Johnson NM, McFadden J. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ 1993; 306:546-549. (Pubitemid 23056872)
47. Lisby G, Milman N, Jacobsen GK. Search for Mycobacterium paratuberculosis DNA in tissue from patients with sarcoidosis by enzymatic gene amplification. APMIS 1993; 101:876-878. (Pubitemid 24053939)
48. Ghossein RA, Ross DG, Salomon RN, Rabson AR. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol 1994; 101:733-737. (Pubitemid 24169307)
49. Popper HH, Winter E, Hofler G. DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. Am J Clin Pathol 1994; 101:738-741. (Pubitemid 24169308)
50. el-Zaatari FA, Naser SA, Markesich DC, et al. Identification of Mycobacterium avium complex in sarcoidosis. J Clin Microbiol 1996; 34:2240-2245. (Pubitemid 26272211)
51. Richter E, Greinert U, Kirsten D, et al. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med 1996; 153:375-380. (Pubitemid 26026877)
52. Cannone M, Vago L, Porini G, et al. [Detection of mycobacterium tuberculosis DNA using nested polymerase chain reaction in lymph nodes with sarcoidosis, fixed in formalin and embedded in paraffin]. Pathologica 1997; 89:512-516. (Pubitemid 127565864)
53. Ozcelik U, Ozkara HA, Gocmen A, et al. Detection of Mycobacterium tuberculosis DNA in tissue samples of children with sarcoidosis. Pediatr Pulmonol 1997; 24:122-124.
54. Popper HH, Klemen H, Hoefler G, Winter E. Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 1997; 28:796-800. (Pubitemid 27298964)
55. Vokurka M, Lecossier D, du Bois RM, et al. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 1997; 156:1000-1003. (Pubitemid 27396448)
56. Vago L, Barberis M, Gori A, et al. Nested polymerase chain reaction for MTB IS6110 sequence on formalin-fixed paraffin-embedded tissues with granulomatous diseases for rapid diagnosis of tuberculosis. Am J Clin Pathol 1998; 109:411-415. (Pubitemid 28151028)
57. Wilsher ML, Menzies RE, Croxson MC. Mycobacterium tuberculosis DNA in tissues affected by sarcoidosis. Thorax 1998; 53:871-874. (Pubitemid 28459545)
58. Grosser M, Luther T, Muller J, et al. Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. Lab Invest 1999; 79:775-784. (Pubitemid 29344489)
59. Ikonomopoulos JA, Gorgoulis VG, Zacharatos PV, et al. Multiplex polymerase chain reaction for the detection of mycobacterial DNA in cases of tuberculosis and sarcoidosis. Mod Pathol 1999; 12:854-862. (Pubitemid 29444550)
60. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999; 354:120-123. (Pubitemid 29313147)
61. Li N, Bajoghli A, Kubba A, Bhawan J. Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J Cutan Pathol 1999; 26:271-278. (Pubitemid 29373924)
62. Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, et al. Sensitive differential detection of genetically related mycobacterial pathogens in archival material. Am J Clin Pathol 2000; 114:940-950. (Pubitemid 33051895)
63. Klemen H, Husain AN, Cagle PT, et al. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung -A PCR-based study on four cases. Virchows Arch 2000; 436:365-369. (Pubitemid 30219235)
64. Drake WP, Pei Z, Pride DT, et al. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002; 8:1334-1341. (Pubitemid 35334710)
65. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002; 40:198-204. (Pubitemid 34027624)
66. Gazouli M, Ikonomopoulos J, Trigidou R, et al. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 2002; 40:3060-3063. (Pubitemid 35284990)
67. Milman N, Lisby G, Friis S, Kemp L. Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:25-28. (Pubitemid 38533810)
68. Grosser M, Luther T, Fuessel M, et al. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:66-74. (Pubitemid 40444737)
69. Marcoval J, Benitez MA, Alcaide F, Mana J. Absence of ribosomal RNA of Mycobacterium tuberculosis complex in sarcoidosis. Arch Dermatol 2005; 141:57-59. (Pubitemid 40144440)
70. Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, et al. Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 2006; 44:3448-3451. (Pubitemid 44413802)
71. Fite E, Fernandez-Figueras MT, Prats R, et al. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 2006; 73:20-26.
72. Xu ML, Zhong HH, Heng WJ, Wu BQ. [Detection of Mycobacterium tuberculosis DNA in sarcoidosis samples using real-time fluorescence polymerase chain reaction]. Zhonghua bing li xue za zhi Chinese J Pathol 2006; 35:735-737.
73. Li QH, Zhao L, Li HP, et al. [Application of quantitative polymerase chain reaction in the differentiation of sarcoidosis and proliferative tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2007; 30:686-690.
74. Zhou Y, Li HP, Li QH, et al. Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25:93-99.
75. Horster R, Kirsten D, Gaede KI, et al. Antimycobacterial immune responses in patients with pulmonary sarcoidosis. Clin Respir J 2009; 3:229-238.
76. Svendsen CB, Milman N, Rasmussen EM, et al. The continuing search for Mycobacterium tuberculosis involvement in sarcoidosis: a study on archival biopsy specimens. Clin Respir J 2011; 5:99-104.
77. Gupta D, Agarwal R, Aggarwal AN, Verma I. Immune responses to mycobacterial antigens in sarcoidosis: a systematic review. Indian J Chest Dis Allied Sci 2011; 53:41-49.
78. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183:469-477. (Pubitemid 32105605)
79. Berthet FX, Rasmussen PB, Rosenkrands I, et al. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 1998; 144 (Pt 11):3195-3203. (Pubitemid 28515598)
80. Kunst H. Diagnosis of latent tuberculosis infection: the potential role of new technologies. Respir Med 2006; 100:2098-2106. (Pubitemid 44724568)
81. Agarwal R, Gupta D, Srinivas R, et al. Analysis of humoral responses to proteins encoded by Region of Difference 1 of Mycobacterium tuberculosis in sarcoidosis in a high tuberculosis prevalence country. Indian J Med Res 2012; 135:(in press).
82. Carlisle J, Evans W, Hajizadeh R, et al. Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol 2007; 150:460-468. (Pubitemid 350098733)
83. Chen ES, Wahlstrom J, Song Z, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008; 181:8784-8796.
84. Drake WP, Dhason MS, Nadaf M, et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007; 75:527-530. (Pubitemid 46047932)
85. Dubaniewicz A, Kampfer S, Singh M. Serum antimycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis. Tuberculosis (Edinb) 2006; 86:60-67. (Pubitemid 41799603)
86. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, et al. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 2007; 12:346-354. (Pubitemid 47164779)
87. Gupta D, Kumar S, Aggarwal AN, et al. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28:95-101.
88. Hajizadeh R, Sato H, Carlisle J, et al. Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol 2007; 27:445-454. (Pubitemid 46906652)
89. Inui N, Suda T, Chida K. Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis. Respir Med 2008; 102:313-315. (Pubitemid 350296913)
90. Milman N, Soborg B, Svendsen CB, Andersen AB. Quantiferon test for tuberculosis screening in sarcoidosis patients. Scand J Infect Dis 2011; 43:728-735.
91. Oswald-Richter KA, Culver DA, Hawkins C, et al. Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun 2009; 77:3740-3748.
92. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005; 201:755-767. (Pubitemid 40395121)
93. Moller DR. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc 2007; 4:465-468. (Pubitemid 47435374)
94. Reich JM. On the nature of sarcoidosis. Eur J Intern Med 2012; 23:105-109.
95. Launois P, DeLeys R, Niang MN, et al. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun 1994; 62:3679-3687. (Pubitemid 24264307)
96. Allen SS, Evans W, Carlisle J, et al. Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Respir Res 2008; 9:36.
97. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001; 167:5217-5225. (Pubitemid 33009758)
98. Oswald-Richter K, Sato H, Hajizadeh R, et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4 T cells when presented by the American sarcoidosis susceptibility allele, DRB1-1101. J Clin Immunol 2010; 30:157-166.
99. Andersen P. The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology 1994; 191:537-547. (Pubitemid 24331480)
100. Dubaniewicz A. Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun Rev 2010; 9:419-424.
101. Kitaichi M. Pathology of pulmonary sarcoidosis. Clin Dermatol 1986; 4:108-115.
102. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007; 28:36-52. (Pubitemid 46364271)
103. Longcope WT, Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 1952; 31:1-132.
104. Sheffield EA. Pathology of sarcoidosis. Clin Chest Med 1997; 18:741-754. (Pubitemid 27525439)
105. Reid L, Lorriman G. Lung biopsy in sarcoidosis, with special reference to bacteriological and microscopic features. Br J Dis Chest 1960; 54:321-334.
106. Mukhopadhyay S, Gal AA. Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med 2010; 134:667-690.
107. Woodring JH, Vandiviere HM, Fried AM, et al. Update: the radiographic features of pulmonary tuberculosis. AJR Am J Roentgenol 1986; 146:497-506. (Pubitemid 16106594)
108. Nishino M, Lee KS, Itoh H, Hatabu H. The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol 2010; 73:66-73.
109. DeRemee RA. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest 1983; 83:128-133.
110. Chugh IM, Agarwal AK, Arora VK, Shah A. Bilateral miliary pattern in sarcoidosis. Indian J Chest Dis Allied Sci 1997; 39:245-249.
111. Gupta D, Kumar S, Jindal SK. Bilateral milliary mottling without hilar lymphadenopathy: a rare presentation of sarcoidosis. Lung India 1996; 14:87-88.
112. Sharma SK, Mohan A, Pande JN, et al. Clinical profile, laboratory characteristics and outcome in miliary tuberculosis. QJM 1995; 88:29-37.
113. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203:359-370. (Pubitemid 43290845)
114. Hudspith BN, Flint KC, Geraint-James D, et al. Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response. Thorax 1987; 42:250-255. (Pubitemid 17058937)
115. Mathew S, Bauer KL, Fischoeder A, et al. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 2008; 181: 746-755.
116. Gupta D, Chetty M, Kumar N, et al. Anergy to tuberculin in sarcoidosis is not influenced by high prevalence of tuberculin sensitivity in the population. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:40-45. (Pubitemid 36564791)
117. Israel HL, Sones M. Sarcoidosis, tuberculosis, and tuberculin anergy. A prospective study. Am Rev Respir Dis 1966; 94:887-895.
118. Lee SS, Liu YC, Huang TS, et al. Comparison of the interferon-gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated healthcare workers. Scand J Infect Dis 2008; 40:373-380. (Pubitemid 351575072)
119. Pal D, Behera D, Gupta D, Aggarwal AN. Tuberculosis in patients receiving prolonged treatment with oral corticosteroids for respiratory disorders. Indian J Tuberc 2002; 49:83-86.
120. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49: 1-51.
121. Tuberculosis associated with blocking agents against tumor necrosis factoralpha: California, 2002-2003 MMWR Morb Mortal Wkly Rep 2004 53 683-686.
122. Hoyle C, Dawson J, Mather G. Treatment of pulmonary sarcoidosis with streptomycin and cortisone. Lancet 1955; 268:638-643.
123. James DG, Thomson AD. The course of sarcoidosis and its modification by treatment. Lancet 1959; 1:1057-1061.
124. Saltini C, Pallante M, Puxeddu E, et al. M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25:100-116.